First Round of Abstract Submission Deadline: April 15, 2026 - Don’t miss out – Early Bird Registration April 17, 2026 - Submit your abstract and secure your spot today!
First Round of Abstract Submission Deadline: April 15, 2026 - Don’t miss out – Early Bird Registration April 17, 2026 - Submit your abstract and secure your spot today!
This track explores how AI, machine learning, and computational modelling accelerate drug discovery. It highlights predictive algorithms, molecular simulations, virtual screening, and data-driven decision-making. Sessions focus on improving accuracy, reducing development time, and identifying high-value drug candidates using advanced digital technologies that transform early research and guide smarter therapeutic design.
This track highlights structure-guided design, fragment screening, and virtual library exploration to accelerate hit discovery. It covers molecular docking, crystallographic insights, biophysical assays, and computational models that help identify promising chemical starting points. Attendees learn efficient screening strategies that improve selection, reduce experimental effort, and support rational, target-focused drug development.
This track explores how early-stage “hits” are identified, evaluated, and improved. It covers high-throughput screening, virtual strategies, fragment libraries, and robust assay development. Sessions emphasize optimizing potency, selectivity, and safety while reducing liabilities. Attendees gain practical insight into transitioning initial hits toward strong lead candidates through integrated computational and experimental workflows.
This track covers modern medicinal chemistry and chemical biology approaches to designing, refining, and optimizing lead compounds. Topics include structure–activity relationships, functional modifications, target engagement, and improving drug-like properties. Attendees learn how interdisciplinary techniques enhance potency, selectivity, and therapeutic relevance while guiding candidates toward successful preclinical development.
This track explores cutting-edge advances in drug delivery platforms and formulation innovations designed to optimize therapeutic outcomes. Topics include controlled and sustained release systems, nano- and micro-delivery carriers, lipid-based formulations, targeted delivery technologies, and solutions for solubility and bioavailability challenges. The session highlights translational strategies, regulatory considerations, and emerging tools that enhance stability, efficacy, patient compliance, and the successful development of next-generation pharmaceuticals and biotherapeutics.
This track focuses on discovering and validating biological targets essential for therapeutic success. Topics include disease pathway analysis, genetic drivers, omics data, and advanced screening tools. Sessions guide attendees through establishing target relevance, reducing development risk, and linking mechanistic insights to translational strategies that shape effective drug design.
This track examines natural products and bioactive molecules as valuable drug discovery resources. It covers extraction technologies, chemical modification, synthetic expansion, and biological characterization. Attendees explore how the structural diversity of natural compounds inspires innovative therapeutics and how medicinal chemistry transforms them into viable candidates.
This track highlights integrated omics technologies used to uncover disease signatures, therapeutic targets, and biomarker opportunities. It covers genomic sequencing, proteomic mapping, transcriptomics, and metabolomics. Participants learn how multi-omics data improves biological understanding, drives precision research, and supports scientifically informed drug discovery decisions.
This track focuses on the discovery, validation, and application of biomarkers to support personalized treatment strategies. It covers diagnostic assay development, patient stratification, treatment monitoring, and regulatory pathways for companion diagnostics. Attendees learn how biomarkers improve clinical outcomes and guide targeted therapeutic interventions.
This track explores the growing landscape of biologics, including antibodies, biosimilars, cell therapies, and engineered proteins. Sessions cover development challenges, analytical methods, manufacturing innovations, and regulatory standards. Attendees gain insights into how biologics provide targeted, effective treatment solutions across multiple disease areas.
This track examines cutting-edge immune-based therapies, including cancer immunotherapies, therapeutic antibodies, vaccines, and immune modulators. Discussions focus on mechanisms of immune activation, combination approaches, emerging targets, and clinical advancements. Attendees gain a deeper understanding of how immunotherapy is reshaping modern disease treatment.
This track covers gene editing breakthroughs, including CRISPR systems and RNA-based treatments. It highlights therapeutic applications, delivery challenges, safety considerations, and emerging engineering tools. Participants learn how gene-modifying strategies address genetic and acquired diseases while enabling highly precise biomedical interventions.
This track focuses on nano-engineered delivery systems designed to improve therapeutic targeting, stability, and controlled release. Topics include lipid nanoparticles, polymeric carriers, nanoemulsions, and advanced delivery technologies. Attendees explore how nanomedicine supports personalized treatments, enhances biosafety, and expands possibilities for complex therapeutic modalities.
This track highlights critical ADME processes, dose–response relationships, safety profiling, and translational approaches that connect preclinical research to clinical application. Sessions cover predictive modelling, toxicological assessment, and strategies for optimizing therapeutic performance. Attendees gain a clear understanding of how PK/PD and safety data inform drug development.
This track addresses global challenges in infectious disease research, including antimicrobial resistance, emerging pathogens, and novel therapeutic approaches. It covers antiviral agents, antibacterial strategies, host-directed therapies, and screening technologies. Participants learn how innovative research supports preparedness and strengthens infectious disease pipelines.
This track focuses on the strategic and ethical aspects of clinical research. It covers trial design, regulatory compliance, patient recruitment, safety management, data integrity, and approval pathways across global markets. Attendees gain practical insights to ensure responsible and efficient clinical development.
This track explores disruptive technologies driving innovation in modern drug discovery. Topics include automation, AI-driven analytics, digital twins, synthetic biology, and next-generation screening tools. Participants learn how these technologies enhance efficiency, improve accuracy, and reshape the research and development landscape.
This track highlights the business and innovation ecosystem behind successful drug development. It covers start-up creation, funding strategies, partnership models, and pathways for translating research into commercial products. Attendees gain insights into fostering innovation, navigating investment challenges, and building sustainable biotech ventures.
By using our websites, you fully and legally accept our terms and conditions. we reserve the right to modify these Terms at any time without prior notice. The most current version of the Terms will always be accessible via the link at the bottom of the Site. Continued use of the Site following the posting of any changes constitutes your acceptance of the revised Terms. Please review the Terms periodically for any updates or modifications. If you do not agree to the terms, you are not authorized to use the site.
Different modes of payment:
Online Mode: Payment for registration can be made separately from the respective conference websites. We have two International Payment gateways: Stripe and PayPal. Both accept payments from all types of cards credit/debit, Visa, Mastercard, and Discover credit cards. American Express cards are not accepted for payment. All the cards must have international transaction enabled. For some payments respective may ask for authorization for completion of registration. We accept in all three currencies USD, EUROs & GBP.
Encryption and Security: the online mod of registration is secured and end to end encrypted. We don’t save or share credit card personal information anywhere, ensuring secure transmission of participant data.
Wire Transfer: Wire/bank transfer can be done from any country. We accept in all three currencies USD, EUROs & GBP.
Offline Mode: This mode of payment is only applicable for cash payment at the registration desk to the conference organizers.
Respective conference hotels confirm hotel reservations from the organizers only after receiving of full payment. Booked accommodations can be cancelled before 45-30 days before the Check in date. It varies from country-to-country hotel policies. Less than 45-30 days of the event, change in the check in-check out date and cancellation will not be allowed and will not be entitled for refund.
Insurance cost is not included in the registration. Registrants are responsible for their parking and transportation. Shuttle facility to and from airport to hotel varies from hotel to hotel. We request you to obtain correct information of the hotel from conference manager or directly from hotel.
Invitation letters will be issued only to the paid registered attendees.
If the registrants are unable to attend for any valid reason are eligible to substitute to another speaker or delegate at least 30 days before the event, request should be made in writing to info@c2pforum.com.
Only fully paid registration including Accommodations (in case) are eligible for transfer of their registration fee to the conference scheduled for the following year, if it falls within 12 months from the date of the affected/cancelled conference. However, the organizers reserve the right to approve or deny such transfer requests, likely to manage logistical and administrative considerations. Discounted cost paid towards accommodation are not eligible to transfer. The registrations transferred are not eligible for any reimbursement.
Filming or recording the conference presentation are not allowed due to privacy concerns from the attendees. Organizer photographer will take the snaps which will be sent to everyone once we get them after editing post 15 days of the event. Participants not interested in filming need to inform in writing to the organizers in prior.
Attendees are sole responsible for the content you upload during the submission process. You must obtain necessary permissions from content owners and indemnify C2P for any failures in obtaining such permissions. C2p will not be responsible for ant third-party content or external links on the website. The attendee will be solely responsible for all their belongings at the venue. Whatever be the reason the organizer will not be responsible for any stolen or missing items of attendees.
By registering for the conference, you authorize C2P Forum to capture, record, and utilize your name, likeness, image, and comments. This includes the right to publish, reproduce, exhibit, distribute, broadcast, edit, and/or digitize these materials in publications, advertising materials, or any other form, worldwide, without compensation. Please note that photographing and/or videotaping during any session is strictly prohibited. For any queries, please contact us.
Heading in the terms and conditions are given for the convenience of readers. It is highly advisable to readd all the terms and conditions before proceeding as it is completer responsibility of the reader only. For any specific queries or clarification, it is advised to contact the conference manager and C2P directly.